tiprankstipranks
BioVaxys Technology (BVAXF)
OTHER OTC:BVAXF
Holding BVAXF?
Track your performance easily

BioVaxys Technology (BVAXF) Financial Statements

30 Followers

BioVaxys Technology Financial Overview

BioVaxys Technology's market cap is currently ―. The company's EPS TTM is $-0.021; its P/E ratio is -2.29; BioVaxys Technology is scheduled to report earnings on February 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 24Apr 24Jan 24Oct 23Jul 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -1.19MC$ -542.39KC$ 518.05KC$ -3.67MC$ -2.92M
EBITDAC$ -1.19MC$ -542.39KC$ 518.05KC$ -3.67MC$ -2.92M
Net Income Common StockholdersC$ -1.19MC$ -542.39KC$ 518.05KC$ -3.67MC$ -2.92M
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 490.85KC$ 159.74KC$ 965.13KC$ 977.00C$ 423.00
Total AssetsC$ 2.41MC$ 1.77MC$ 1.48MC$ 113.48KC$ 1.41M
Total DebtC$ 81.21KC$ 64.96KC$ 98.13KC$ 0.00C$ 0.00
Net DebtC$ -409.64KC$ -94.78KC$ -867.01KC$ -977.00C$ -423.00
Total LiabilitiesC$ 2.66MC$ 2.79MC$ 2.87MC$ 3.49MC$ 2.04M
Stockholders EquityC$ -249.19KC$ -1.03MC$ -1.40MC$ -3.37MC$ -624.21K
Cash Flow-
Free Cash FlowC$ -412.20KC$ -1.49MC$ 2.38KC$ -2.02KC$ -23.74K
Operating Cash FlowC$ -412.20KC$ -436.93KC$ 2.38KC$ -2.02KC$ -23.74K
Investing Cash FlowC$ -1.00C$ -1.06M---
Financing Cash FlowC$ 743.40KC$ 687.94KC$ 962.67K--
Currency in CAD

BioVaxys Technology Earnings and Revenue History

BioVaxys Technology Debt to Assets

BioVaxys Technology Cash Flow

BioVaxys Technology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis